Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
A decade experience of cardiac retransplantation in adult recipients
Veli K. Topkara
, Nicholas C. Dang
,
Ranjit John
, Faisal H. Cheema
, Raffaele Barbato
, Marco Cavallo
, Judy F. Liu
, Lorraine M. Liang
, Elyse A. Liberman
, Michael Argenziano
, Mehmet C. Oz
, Yoshifumi Naka
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A decade experience of cardiac retransplantation in adult recipients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Retransplant
100%
Cardiac Retransplantation
100%
Adult Recipients
100%
Transplantation
50%
Cytomegalovirus
33%
Retransplantation
33%
Survival Rate
33%
Early Mortality
33%
Serology
33%
Transplant Recipients
16%
Risk Assessment
16%
Short-term Outcomes
16%
Adult Patients
16%
Coronary Artery Disease
16%
Acute Rejection
16%
Ethical Issues
16%
Left Ventricular Assist Device
16%
Cardiac Transplantation
16%
Therapeutic Potential
16%
Comorbidity
16%
Organ Donor
16%
Poor Outcome
16%
Cardiac Allograft
16%
Pretransplant
16%
Donor Age
16%
Patient Selection
16%
Surgical Options
16%
Post-transplant Survival
16%
Donor Organs
16%
Baseline Characteristics
16%
Recipient Age
16%
Long-term Survival Rate
16%
Ischemic Time
16%
End-stage Heart Failure
16%
Logistic Problem
16%
Donor Demographics
16%
Time Rate
16%
Financial Issues
16%
Device Use
16%
Actuarial Survival
16%
In(III)
16%
Patient Risk
16%
Medicine and Dentistry
Retransplantation
100%
Survival Rate
60%
Organ Donor
40%
Cytomegalovirus
40%
Graft Survival
40%
Heart Muscle Ischemia
20%
Left Ventricular Assist Device
20%
Allograft
20%
Coronary Artery Disease
20%
Heart Transplantation
20%
Acute Graft Rejection
20%
Congestive Heart Failure
20%
Long Term Survival
20%
Patient Selection
20%
Comorbidity
20%